ISDA

Entry Detail

PDB ID:

3FCO

Keywords:

OXIDOREDUCTASE

Title:

Crystal Structure of 11beta-Hydroxysteroid Dehydrogenase 1 (11b-HSD1) in Complex with Benzamide Inhibitor

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2008-11-21

Release Date:

2009-12-01

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.65 Å

R-Value Free:

0.25

R-Value Work:

0.22

R-Value Observed:

0.22

Space Group:

P 31 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Corticosteroid 11-beta-dehydrogenase isozyme 1
Mutations:C272S
Chain IDs:A, B
Chain Length:286
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P28845 Pfam ID:PF00106 EC:1.1.1.146

Ligand Molecules

IIG

NAP

Primary Citation

Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11 beta-HSD1 inhibitors.

McMinn, D.L, Rew, Y, Sudom, A, Caille, S, Degraffenreid, M, He, X, Hungate, R, Jiang, B, Jaen, J, Julian, L.D, Kaizerman, J, Novak, P, Sun, D, Tu, H, Ursu, S, Walker, N.P, Yan, X, Ye, Q, Wang, Z, Powers, J.P.Show

Bioorg.Med.Chem.Lett. 19 1446 1450 (2009)

PMID: 19185488 DOI: 10.1016/j.bmcl.2009.01.026

Abstact

Novel 4,4-disubstituted cyclohexylbenzamide inhibitors of 11beta-HSD1 were optimized to account for liabilities relating to in vitro pharmacokinetics, cytotoxicity and protein-related shifts in potency. A representative compound showing favorable in vivo pharmacokinetics was found to be an efficacious inhibitor of 11beta-HSD1 in a rat pharmacodynamic model (ED(50)=10mg/kg).

Legend

Protein

Chemical

Disease

Primary Citation of related structures